20 August 2021
The Therapeutic Goods Administration (TGA) will rigorously assess any COVID-19 treatment for safety, quality and effectiveness before it can be registered for use in Australia. This page will be regularly updated to keep consumers, health professionals and sponsors informed of the latest regulatory developments.
For links to the latest information on all COVID-19 related work being undertaken by the TGA and the Department of Health, please visit the COVID-19 hub.